Skip to main content
. 2019 Aug 12;9:11632. doi: 10.1038/s41598-019-48064-w

Figure 1.

Figure 1

Introduction of SH3GL2 inhibited tumorigenic progression of BCa cells in vitro and in vivo and decreased SPANXB1 expression. SH3GL2 overexpression in SUM-159 cells (A) reduced invasion (B), filopodium like protrusion formation (C) and pulmonary metastasis (arrows) in vivo (D). (E) Microarray analysis of SH3GL2-overexpressing SUM-159 cells exhibited 12.1 fold decrease of SPANXB1 mRNA expression (arrow). (F) SH3GL2 overexpression reduced SPANXB1 expression in TNBC cells. VC: Empty vector control; SH3GL2: SH3GL2 transduced (AD). VC: Empty vector control; GL2: SH3GL2 transduced (F). Magnification × 200 (B,C). In Western blotting, all experimental and control antibodies were run in parallel for the same immunoblot. The Image J software (https://imagej.nih.gov/ij/) was used for Western blot quantification.